arrow_back Back to App

FDA Security Rules: Employment Restrictions to Protect Medicine and Device Safety

This Act establishes strict employment rules at the Food and Drug Administration (FDA) to shield the drug and medical device approval process from foreign influence. Citizens can expect these changes to enhance the safety and integrity of medical products available on the market. The new rules restrict the hiring of individuals connected to China, Russia, or Iran and impose a 10-year post-employment work ban related to those countries.
Key points
Nationals of China, Russia, or Iran are ineligible for employment or paid services at the FDA.
FDA employees must report if immediate family members (parents, siblings, children) are nationals of these countries; failure to report results in immediate termination.
A 10-year ban is imposed on former FDA employees working for entities based in China, Russia, or Iran.
Employees with family or prior work ties to these countries face limitations on accessing sensitive drug and device data within the FDA.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2986
Sponsor: Sen. Cotton, Tom [R-AR]
Process start date: 2025-10-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

American Medicine Safety and Security Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2986.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-10-08.

What are the main provisions?

Key points include:

  • Nationals of China, Russia, or Iran are ineligible for employment or paid services at the FDA.
  • FDA employees must report if immediate family members (parents, siblings, children) are nationals of these countries; failure to report results in immediate termination.
  • A 10-year ban is imposed on former FDA employees working for entities based in China, Russia, or Iran.
  • Employees with family or prior work ties to these countries face limitations on accessing sensitive drug and device data within the FDA.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cotton, Tom [R-AR].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Security